ArticleJournal of gynecology obstetrics and human reproduction2021
COVID-19 impact in abortions' practice, a regional French evaluation.
Article in Journal of gynecology obstetrics and human reproduction, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Abortion services during the COVID-19 pandemic: a systematic review.Reproductive health · 2023Pooled it
- [Innovation in abortion care during the COVID-19 pandemic in Germany, France and Great Britain : Paths to maintaining access and building system resilience].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025Review
- COVID-19 and abortion in the Ohio River Valley: A case study of Kentucky, Ohio, and West Virginia.Perspectives on sexual and reproductive health · 2023Article
- Impact of the COVID-19 pandemic and the emergency measures on abortion care taken during this period in a French region (Provence Alpes Côte d'Azur).Journal of gynecology obstetrics and human reproduction · 2022Article
- Impact of the COVID-19 pandemic on access to and utilisation of services for sexual and reproductive health: a scoping review.BMJ global health · 2022Article
- Article
- The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.Family practice · 2021Article
- Safeguarding and teleconsultation for abortion.Lancet (London, England) · 2021Review
- Abortion care in a pandemic: an analysis of the number and social profile of people requesting and receiving abortion care during the first COVID-19 lockdown (March 16 to June 14, 2020) in Flanders, Belgium.Archives of public health = Archives belges de sante publique · 2021Article
- How can countries create outbreak response policies that are sensitive to maternal health?BMJ (Clinical research ed.) · 2021Article
- Easing of Regulatory Barriers to Telemedicine Abortion in Response to COVID-19.Frontiers in global women's health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOn March 14, 2020, France has entered into stage 3 of the COVID-19 pandemic. The French National Health Agency (Haute Autorité de Santé) has urgently recommended the use of medical abortion at home between 7 and 9 weeks of gestation and telemedicine for medical abortion consultations. The main objective of this study was to assess whether the emergency measures undertaken for the management of abortions during the COVID-19 pandemic led to practice changes, and to obtain practitioners' opinions regarding the continuation of these measures. MATERIAL AND
methodsThis was a retrospective, quantitative, online self-administered survey from August 6, 2020 to October 2, 2020, aimed at health workers performing abortions (midwives, general practitioners, gynecologists obstetricians and medical gynecologists) in the South and Corse regions in France.
resultsAmong the 124 practitioners included, 59/77 (76.6 %) offered medical abortion at home between 7 and 9 weeks of gestation and 61/89 (68.5 %) of them wished to carry on this practice. 55/123 (44.7 %) practitioners offered telemedicine for medical abortion at home and 71/115 (61.7 %) of them wished to carry on this practice. DISCUSSION: The emergency measures implemented by the the French National Health Agency (Haute Autorité de Santé) for medical abortion are approved and followed by the majority of health workers performing abortions in the South and Corse regions. This measure may be extended out of the COVID-19 epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.